Population health model predicting the long-term impact of sotatercept on morbidity and mortality in patients with Pulmonary Arterial Hypertension (PAH)

被引：0
|
作者：
Mclaughlin, Vallerie [1 ]
Alsumali, Adnan [2 ]
Klok, Rogier [2 ]
Liu, Rongzhe [3 ]
Martinez, Eliana [2 ]
Chevure, Jestinah [2 ]
Pena, Janethe De Oliveira [2 ]
Lautsch, Dominik [2 ]
Hoeper, Marius [4 ,5 ]
机构：
[1] Univ Michigan Hlth Syst, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA
[2] Merck & Co Inc, Rahway, NJ 07065 USA
[3] OPEN Hlth, Bethesda, MD USA
[4] Hannover Med Sch, Dept Resp Dis, Hannover, Germany
[5] Hannover Med Sch, German Ctr Lung Res DZL, Hannover, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.OA740
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)
    Mclaughlin, Vallerie
    Alsumali, Adnan
    Liu, Rongzhe
    Klok, Rogier
    Martinez, Eliana C.
    Nourhussein, Iman
    Bernotas, David
    Chevure, Jestinah
    Pausch, Christine
    Pena, Janethe De Oliveira
    Lautsch, Dominik
    Hoeper, Marius M.
    ADVANCES IN THERAPY, 2024, 41 (01) : 130 - 151
  • [2] Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)
    Vallerie McLaughlin
    Adnan Alsumali
    Rongzhe Liu
    Rogier Klok
    Eliana C. Martinez
    Iman Nourhussein
    David Bernotas
    Jestinah Chevure
    Christine Pausch
    Janethe De Oliveira Pena
    Dominik Lautsch
    Marius M. Hoeper
    Advances in Therapy, 2024, 41 : 130 - 151
  • [3] Late Breaking Abstract - A long-term follow-up (LTFU) study of sotatercept for pulmonary arterial hypertension (PAH)
    Preston, Ioana R.
    Badesch, David
    Ghofrani, Hossein-Ardeschir
    Gibbs, J. Simon R.
    Gomberg-Maitland, Mardi
    Hoeper, Marius M.
    Humbert, Marc
    Mclaughlin, Vallerie V.
    Waxman, Aaron B.
    Manimaran, Solaiappan
    Mikhailova, Elina
    Pena, Janethe De Oliveira
    De Souza, Rogerio
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Humbert, M.
    Mclaughlin, V. V.
    Gibbs, S. R.
    Gomberg-Maitland, M.
    Hoeper, M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Ghofrani, H. A.
    Subias, P. Escribano
    Feldman, J. P.
    Bohns Meyer, G.
    Montani, D.
    Olsson, K. M.
    Manimaran, S.
    Pena, J. de Oliveira
    Badesch, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [5] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466
  • [6] Impact of initial treatment strategy on long-term survival in pulmonary arterial hypertension (PAH)
    Boucly, Athenais
    Savale, Laurent
    Weatherald, Jason
    Montani, David
    Jevnikar, Mitja
    Jais, Xavier
    Simonneau, Gerald
    Humbert, Marc
    Sitbon, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [7] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [8] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
  • [9] Predicting mortality during long-term follow-up in pulmonary arterial hypertension
    Kylhammar, David
    Hjalmarsson, Clara
    Hesselstrand, Roger
    Jansson, Kjell
    Kavianipour, Mohammad
    Kjellstrom, Barbro
    Nisell, Magnus
    Soderberg, Stefan
    Radegran, Goran
    ERJ OPEN RESEARCH, 2021, 7 (02)
  • [10] Impact of Initial Triple Combination Therapy on Long-Term Survival in Pulmonary Arterial Hypertension (PAH)
    Boucly, A.
    Savale, L.
    Weatherald, J. C.
    Montani, D.
    Cottin, V.
    Dauphin, C.
    Picard, F.
    Fard, D.
    Mignard, X.
    Jutant, E.
    Jevnikar, M.
    Jais, X.
    Simonneau, G.
    Humbert, M.
    Sitbon, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345